Jonathan D Alpern

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 6

Top Topics

Health Insurance

Drug Administration

Plasmodium Falciparum

Top Venues

PLoS neglected tropical diseases

Open forum infectious diseases

Journal of fungi (Basel, Switzerland)

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

This page only lists publications with an associated author ORCID identifier.

Publications

Joohyun Park, Heesoo Joo, Brian A Maskery, Jonathan D Alpern, Michelle Weinberg, William M Stauffer
Costs of malaria treatment in the United States. Journal of travel medicine (2023)
Jonathan D Alpern, Heesoo Joo, Nathan C Bahr, Thomas M Leventhal
Factors Associated With Adherence to First-line Antiviral Therapy Among Commercially Insured Patients With Chronic Hepatitis B. Open forum infectious diseases 10 (3) (2023)
Matthew F Pullen, Jonathan D Alpern, Nathan C Bahr
Blastomycosis-Some Progress but Still Much to Learn. Journal of fungi (Basel, Switzerland) 8 (8) (2022)
Christine M Thomas, William M Stauffer, Jonathan D Alpern
FDA Approval of Artesunate for Severe Malaria-Enough to Achieve Best Practice? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)
Jonathan D Alpern, Stephen J Dunlop, William M Stauffer
Broken drug markets in infectious diseases: Opportunities outside the private sector? PLoS neglected tropical diseases 13 (4) (2019)
Jonathan D Alpern, Rogelio Lopez-Velez, William M Stauffer
Access to benznidazole for Chagas disease in the United States-Cautious optimism? PLoS neglected tropical diseases 11 (9) (2017)